Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer
Immune checkpoint blockade may represent a promising nonsurgical treatment option for patients with locally advanced dMMR/MSI-H rectal cancer.
Authors
- Yasufumi Otsuki (ORCID: https://orcid.org/0000-0002-5794-5115)
- Rin Yamada (ORCID: https://orcid.org/0000-0001-9161-1429)
- Tsuyoshi Fukushima (ORCID: https://orcid.org/0000-0002-9350-777X)
- Yoshihiro Komohara (ORCID: https://orcid.org/0000-0001-9723-0846)
- Hotaka Tamura
- Ayumu Hosokawa (ORCID: https://orcid.org/0009-0003-6913-6950)
- Akiko Ichihara
Institutions
- University of Miyazaki (JP)
- University of Miyazaki Hospital (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-10-28
- DOI
- https://doi.org/10.21873/anticanres.17847
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00